Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome

References

• Xu X, Wang G, Chen N, et al. Long-Term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27(12):1–11.
   PubMed Web of Science ®Google Scholar
• Ronco P, Beck L, Debiec H, et al. Membranous nephropathy. Nat Rev Dis Primers. 2021;7(1):69. doi:10.1038/s41572-021-00303-z.
   PubMed Web of Science ®Google Scholar
• Seitz-Polski B, Dahan K, Debiec H, et al. High-Dose rituximab and early remission in PLA2R1-Related membranous nephropathy. Clin J Am Soc Nephrol. 2019;14(8):1173–1182.
   PubMed Web of Science ®Google Scholar
• Reinhard L, Zahner G, Menzel S, et al. Clinical relevance of domain-specific phospholipase a receptor 1 antibody levels in patients with membranous nephropathy. J Am Soc Nephrol. 2020;31(1):197–207.
   PubMed Web of Science ®Google Scholar
• Nieto-Gañán I, Iturrieta-Zuazo I, Rita C, et al. Revisiting immunological and clinical aspects of membranous nephropathy. Clin Immunol. 2022;237:108976.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu W, Wang Y. Prognostic role of preoperative fibrinogen to albumin ratio in breast cancer. Clin Chim Acta. 2020;510:360–362. doi:10.1016/j.cca.2020.07.055.
   PubMed Web of Science ®Google Scholar
• Zou Y-X, Qiao J, Zhu H-Y, et al. Albumin-to-fibrinogen ratio as an independent prognostic parameter in untreated chronic lymphocytic leukemia: a retrospective study of 191 cases. Cancer Res Treat. 2019;51(2):664–671. doi:10.4143/crt.2018.358.
   PubMed Web of Science ®Google Scholar
• Lee LE, Pyo JY, Ahn SS, et al. Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Lab Anal. 2021;35(4):e23731.
   PubMed Web of Science ®Google Scholar
• Zou Y, Zhu Z, Zhou J, et al. Fibrinogen/albumin ratio: a more powerful prognostic index for patients with end-stage renal disease. Eur J Clin Invest. 2020; 50(8):e13266.
   Web of Science ®Google Scholar
• Wang H, Zheng C, Lu Y, et al. Urinary fibrinogen as a predictor of progression of CKD. Clin J Am Soc Nephrol. 2017;12(12):1922–1929. doi:10.2215/CJN.01360217.
   PubMed Web of Science ®Google Scholar
• Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022;18(7):466–478. doi:10.1038/s41581-022-00564-1.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, 3rd, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295(14):741–746. doi:10.1056/NEJM197609302951401.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753–779.
   PubMed Web of Science ®Google Scholar
• Sheinenzon A, Shehadeh M, Michelis R, et al. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857–862.
   PubMed Web of Science ®Google Scholar
• Jensen T, Kierulf P, Sandset PM, et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost. 2007;97(5):822–829. doi:10.1160/th07-01-0039.
   PubMed Web of Science ®Google Scholar
• Anders H-J, Banas B, Schlöndorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15(4):854–867. doi:10.1097/01.asn.0000121781.89599.16.
   PubMed Web of Science ®Google Scholar
• Chen K, Huang J, Gong W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007;7(10):1271–1285. doi:10.1016/j.intimp.2007.05.016.
   PubMed Web of Science ®Google Scholar
• Yu W, Ye Z, Fang X, et al. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer. J Ovarian Res. 2019;12(1):88. doi:10.1186/s13048-019-0563-8.
   PubMedGoogle Scholar
• Ying J, Zhou D, Gu T, et al. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy. BMC Cancer. 2019;19(1):288. doi:10.1186/s12885-019-5490-y.
   PubMed Web of Science ®Google Scholar
• Wang P, Yuan D, Zhang C, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21(1):46. doi:10.1186/s12933-022-01477-w.
   PubMed Web of Science ®Google Scholar
• Park S, Nam K, Kim TK. Association between preoperative fibrinogen-to-albumin ratio and all-Cause mortality after off-Pump coronary artery bypass grafting: a retrospective observational study. Anesth Analg. 2022;134(5):1021–1027. doi:10.1213/ANE.0000000000005948.
   PubMed Web of Science ®Google Scholar
• Xie J, Liu L, Mladkova N, et al. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat Commun. 2020;11(1):1600. doi:10.1038/s41467-020-15383-w.
   PubMed Web of Science ®Google Scholar
• Cremoni M, Brglez V, Perez S, et al. Th17-Immune response in patients with membranous nephropathy is associated with thrombosis and relapses. Front Immunol. 2020;11:574997. doi:10.3389/fimmu.2020.574997.
   PubMed Web of Science ®Google Scholar
• Chen R, Li H, Cai J, et al. Fine particulate air pollution and the expression of microRNAs and circulating cytokines relevant to inflammation, coagulation, and vasoconstriction. Environ Health Perspect. 2018;126(1):017007. doi:10.1289/EHP1447.
   PubMed Web of Science ®Google Scholar
• Liu W, Gao C, Dai H, et al. Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role. Front Immunol. 2019;10:1809. doi:10.3389/fimmu.2019.01809.
   PubMed Web of Science ®Google Scholar
• van de Logt AE, Fresquet M, Wetzels JF, et al. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019;96(6):1292–1302.
   PubMed Web of Science ®Google Scholar
• Qin Z, Li H, Wang L, et al. Systemic immune-inflammation index is associated with increased urinary albumin excretion: a population-based study. Front Immunol. 2022;13:863640. doi:10.3389/fimmu.2022.863640.
   PubMed Web of Science ®Google Scholar
• Scolari F, Alberici F, Mescia F, et al. Therapies for membranous nephropathy: a tale from the old and new millennia. Front Immunol. 2022;13:789713. doi:10.3389/fimmu.2022.789713.
   PubMed Web of Science ®Google Scholar